ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)

Providence, R.I., and Osaka, JAPAN, April 23, 2020 – ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited [TSE:4502/NYSE:TAK] (“Takeda”) today announced that they have entered into a global licensing agreement to develop a novel plasma-derived...
Jay Round, RI Bio’s Entrepreneur in Residence on GoLocalProv

Jay Round, RI Bio’s Entrepreneur in Residence on GoLocalProv

Jay Round, RI Bio’s Entrepreneur in Residence, sat down with Josh Fenton of GoLocalProv to discuss the developing life science sector in the Ocean State. Highlights include RI’s new neurology R&D institutions, an incredibly promising, homegrown ocular therapy...